These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 15156445

  • 1. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T, Asian Network for Surveillance of Resistant Pathogens Study Group.
    Clin Infect Dis; 2004 Jun 01; 38(11):1570-8. PubMed ID: 15156445
    [Abstract] [Full Text] [Related]

  • 2. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W, Assawasanti K, Chaimanee P.
    Southeast Asian J Trop Med Public Health; 2006 Mar 01; 37(2):320-6. PubMed ID: 17124993
    [Abstract] [Full Text] [Related]

  • 3. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
    Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F.
    N Engl J Med; 1995 Aug 24; 333(8):474-80. PubMed ID: 7623879
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C.
    J Lab Clin Med; 2004 May 24; 143(5):269-83. PubMed ID: 15122171
    [Abstract] [Full Text] [Related]

  • 6. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C, Armengol R, Mir I, Lite J, Garau J.
    Enferm Infecc Microbiol Clin; 1992 May 24; 10(6):334-9. PubMed ID: 1391015
    [Abstract] [Full Text] [Related]

  • 7. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
    Mufson MA, Chan G, Stanek RJ.
    Am J Med Sci; 2007 Mar 24; 333(3):161-7. PubMed ID: 17496734
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP, Hofmann J, Cetron MS, Fine MJ, Farley MM, Whitney C, Breiman RF.
    Clin Infect Dis; 2000 Mar 24; 30(3):520-8. PubMed ID: 10722438
    [Abstract] [Full Text] [Related]

  • 10. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [Abstract] [Full Text] [Related]

  • 11. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P, Lescure FX, Douadi Y, Schmit JL, Jounieaux V, Laurans G, Eb F, Ducroix JP.
    J Infect; 2005 Jul 15; 51(1):69-76. PubMed ID: 15979494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Current use of penicillin in community-acquired pneumococcal pneumonias].
    Gaztelurrutia L, Zalacaín R, Rubio G, Hernández JL, Urra E, Hernández M, Garea C, Barrón J.
    Enferm Infecc Microbiol Clin; 1994 Jan 15; 12(1):17-20. PubMed ID: 8155749
    [Abstract] [Full Text] [Related]

  • 14. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, Grayson ML, Australian CAP Study Collaboration.
    Clin Infect Dis; 2008 May 15; 46(10):1513-21. PubMed ID: 18419484
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.
    Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH, Phelan M, Facklam RR, Cetron MS, Breiman RF, Kolczak M, Schuchat A.
    Clin Infect Dis; 2001 Sep 15; 33(6):797-805. PubMed ID: 11512085
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F, Cuadrado JM, Andreu L, Martínez S, Cañizares R, de la Tabla VO, Martin C, Roig P, Merino J.
    Eur J Intern Med; 2008 Jan 15; 19(1):15-21. PubMed ID: 18206596
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
    Soriano F.
    Med Clin (Barc); 1999 Jun 26; 113(3):103-8. PubMed ID: 10464745
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap?
    Wiener-Well Y, Raveh D, Schlesinger Y, Yinnon AM, Rudensky B.
    Chemotherapy; 2009 Jun 26; 55(2):97-104. PubMed ID: 19145079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.